Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

NPSA Testing Update

6 Oct 2025 13:49

RNS Number : 2402C
Thruvision Group PLC
06 October 2025
 

Reach - non-regulatory announcement

 

6 October 2025

Thruvision Group plc

UK Government National Protective Security Authority ("NPSA") testing update

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology ("Thruvision" or the "Company" and, together with its subsidiary undertakings, the "Group"), today announces that the Thruvision LPCDD7116 has been tested following the NPSA's Discriminative Threat Detection Systems Test Method. The testing is not pass/fail but shows that the system has capability for screening non-divested individuals for mass casualty threats.

 

The NPSA has confidence that Thruvision has followed the NPSA's Discriminative Threat Detection Systems Test Method in the testing of the Thruvision LPCDD7116 and the results presented are an accurate reflection of system performance. The test method is not pass/fail and the NPSA does not endorse or approve specific products tested against it.

 

Notes for readers:

· The NPSA are the UK Government's National Technical Authority for physical and personnel security.

· As part of the Security Service, MI5, the NPSA make the UK more resilient to terrorism and state threats.

· The results are available to security professionals and buyers interested in detecting both metallic and non-metallic threats to help them understand detection performance and throughput to align with their requirements to secure their facility from current and emerging threats.

· The LPCDD7116 is the catalogue number for our standard equipment.

 

For further information please contact:

 

Thruvision Group plc

Tom Black, Executive Chairman

Victoria Balchin, Chief Executive Officer and Chief Financial Officer

+44 (0)1235 425400

Allenby Capital Limited (NOMAD & Broker)

James Reeve / Piers Shimwell (Corporate Finance)

Jos Pinnington / Amrit Nahal (Sales)

+44 (0)20 3328 5656

 

About Thruvision (www.thruvision.com)

Thruvision is a leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAAEKELKSFFA
Date   Source Headline
31st May 20245:06 pmRNSHolding(s) in Company
30th May 20247:00 amRNSThruvision partners with Sensormatic Solutions
22nd May 202412:26 pmRNSBlock listing Interim Review
22nd May 202412:26 pmRNSBlock listing Interim Review
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.